Early Detection for a Healthier Pregnancy Journey
Congenital Anomaly Screening is an essential part of prenatal care that helps assess your baby's development and identify certain structural abnormalities before birth. At Sattva The Fetal Medicine Centre, we provide advanced Congenital Anomaly Screening using high-resolution ultrasound, Level II Anomaly Scan, prenatal assessment, and personalized maternal-fetal care. Our goal is to support early diagnosis, informed decision-making, and the best possible pregnancy outcomes.
What is Congenital Anomaly Screening?
Congenital Anomaly Screening is a specialized prenatal evaluation performed during pregnancy to assess the baby's organs, bones, and overall anatomical development. The screening helps identify structural birth defects that may affect the brain, heart, spine, face, kidneys, abdomen, limbs, or other body systems.
Early detection allows families to receive expert counselling, appropriate monitoring, and personalized pregnancy management. If any abnormality is suspected, additional diagnostic tests or specialized fetal medicine consultation may be recommended to better understand the condition and plan appropriate care for both mother and baby.
Early prenatal screening helps families understand their pregnancy, assess the likelihood of chromosomal conditions, and make informed decisions about further evaluation and personalized pregnancy care.
At Sattva The Fetal Medicine Centre, comprehensive prenatal screening helps estimate the likelihood of common chromosomal abnormalities and supports early identification of pregnancies that may benefit from additional evaluation, genetic counselling, or diagnostic testing.
The primary focus of prenatal screening is to estimate the likelihood that the baby may have Down syndrome (Trisomy 21), the most common chromosomal condition screened during pregnancy.
Screening also evaluates the risk of Edwards syndrome (Trisomy 18), a rare chromosomal condition associated with serious developmental abnormalities.
Risk assessment includes screening for Patau syndrome (Trisomy 13), another uncommon chromosomal condition that can affect multiple organ systems.
Depending on individual circumstances, ultrasound evaluation may also assess for certain fetal structural abnormalities that require further investigation.
Additional assessments may help identify pregnancy-related concerns, supporting timely referral, personalized care, and appropriate follow-up throughout pregnancy.
An increased-risk screening result does not mean that your baby definitely has Down syndrome. It simply indicates that the likelihood is higher than expected. Our Maternal & Fetal Medicine specialists carefully review your results, explain their meaning, and guide you through the most appropriate next steps based on your individual pregnancy.
A highly accurate blood test that further evaluates the risk of common chromosomal conditions without posing a risk to the pregnancy.
A diagnostic procedure performed during early pregnancy to confirm or exclude certain chromosomal abnormalities when clinically indicated.
A diagnostic test that analyzes amniotic fluid to provide a definitive diagnosis of many chromosomal conditions when recommended.
A comprehensive ultrasound examination to evaluate fetal anatomy and identify any structural findings that may require further assessment.
Continued consultation with our fetal medicine specialists to interpret results, discuss available options, and provide personalized pregnancy management and follow-up care.
At Sattva The Fetal Medicine Centre, we follow a structured, evidence-based prenatal screening process to provide accurate risk assessment, expert counselling, and personalized maternal-fetal care. Every step is designed to help you better understand your pregnancy and make informed healthcare decisions.
Review of your pregnancy history, medical background, family history, and individual risk factors to plan appropriate prenatal screening.
Comprehensive NT Scan and first-trimester assessment, along with recommended prenatal screening tests, to evaluate chromosomal risk.
Detailed interpretation of ultrasound findings, maternal blood test results, and clinical information to calculate your individualized screening risk.
Discussion of your screening results, explanation of their significance, and recommendations for any additional testing or specialist consultation if needed.
Personalized follow-up, continued maternal-fetal monitoring, and expert pregnancy care to support the health of both mother and baby throughout pregnancy.
Find answers to common questions about Down Syndrome Screening, First Trimester Screening, NT Scan, and prenatal risk assessment at Sattva The Fetal Medicine Centre.
No. Down Syndrome Screening is a screening test that estimates the likelihood of Down syndrome (Trisomy 21). Diagnostic tests such as Chorionic Villus Sampling (CVS) or amniocentesis are required to confirm the diagnosis when clinically appropriate.
It is generally performed between 11 weeks and 13 weeks 6 days of pregnancy as part of First Trimester Screening, which includes the NT Scan and maternal blood tests.
Yes. Down Syndrome Screening is safe and non-invasive. It involves an ultrasound examination (NT Scan) and maternal blood tests, without exposing the mother or baby to radiation.
No screening test can provide a 100% guarantee. However, a low-risk screening result is reassuring and indicates that the likelihood of Down syndrome is lower than expected.
If your screening result indicates an increased risk, your healthcare provider may recommend additional evaluation such as Non-Invasive Prenatal Testing (NIPT), CVS, amniocentesis, or a detailed fetal ultrasound, depending on your individual pregnancy and clinical findings.
